WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience PeproTech - Your Source for Neuroscience Research Reagents
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (110)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xia, X.-M.
Right arrow Articles by Lingle, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xia, X.-M.
Right arrow Articles by Lingle, C. J.

 Previous Article  |  Next Article 

The Journal of Neuroscience, July 1, 1999, 19(13):5255-5264

Molecular Basis for the Inactivation of Ca2+- and Voltage-Dependent BK Channels in Adrenal Chromaffin Cells and Rat Insulinoma Tumor Cells

Xiao-Ming Xia 1, Jiu Ping Ding 1, and Christopher J. Lingle 1, 2

Departments of 1 Anesthesiology and 2 Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri 63110


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Large-conductance Ca2+- and voltage-dependent potassium (BK) channels exhibit functional diversity not explained by known splice variants of the single Slo alpha -subunit. Here we describe an accessory subunit (beta 3) with homology to other beta -subunits of BK channels that confers inactivation when it is coexpressed with Slo. Message encoding the beta 3 subunit is found in rat insulinoma tumor (RINm5f) cells and adrenal chromaffin cells, both of which express inactivating BK channels. Channels resulting from coexpression of Slo alpha  and beta 3 subunits exhibit properties characteristic of native inactivating BK channels. Inactivation involves multiple cytosolic, trypsin-sensitive domains. The time constant of inactivation reaches a limiting value ~25-30 msec at Ca2+ of 10 µM and positive activation potentials. Unlike Shaker N-terminal inactivation, but like native inactivating BK channels, a cytosolic channel blocker does not compete with the native inactivation process. Finally, the beta 3 subunit confers a reduced sensitivity to charybdotoxin, as seen with native inactivating BK channels. Inactivation arises from the N terminal of the beta 3 subunit. Removal of the beta 3 N terminal (33 amino acids) abolishes inactivation, whereas the addition of the beta 3 N terminal onto the beta 1 subunit confers inactivation. The beta 3 subunit shares with the beta 1 subunit an ability to shift the range of voltages over which channels are activated at a given Ca2+. Thus, the beta -subunit family of BK channels regulates a number of critical aspects of BK channel phenotype, including inactivation and apparent Ca2+ sensitivity.

Key words: accessory subunits; K+ channels; BK channels; Ca2+- and voltage-gated K+ channels; mSlo channels; inactivation


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Large-conductance calcium (Ca2+) and voltage-gated K+ channels are widely expressed channels (McManus, 1991) that couple changes in submembrane Ca2+ concentration ([Ca2+]i) to the regulation of electrical excitability. BK channels are formed from four alpha -subunits (Shen et al., 1994) arising from the Slo gene product (Atkinson et al., 1991; Adelman et al., 1992; Butler et al., 1993). In addition, in some tissues, including smooth muscle (Knaus et al., 1994a,b) and cochlea (Ramanathan et al., 1999), an accessory beta -subunit can regulate BK channel gating profoundly. beta -Subunits appear to be responsible for the increased sensitivity of smooth muscle BK channels to Ca2+ (McManus et al., 1995) and may play a role in the frequency tuning of hair cells (Ramanathan et al., 1999). Although beta -subunits may account for some of the diversity of BK channels, the BK phenotype in many cells remains unexplained (McManus, 1991). For example, in adrenal chromaffin cells (Solaro and Lingle, 1992), pancreatic beta -cell lines (Li et al., 1999), and in the hippocampus (Hicks and Marrion, 1998) some BK channels exhibit inactivation. Furthermore, in Drosophila flight muscles (Salkoff, 1983) and perhaps in hair cells (Armstrong and Roberts, 1999), there are inactivating Ca2+-dependent currents probably arising from the Slo gene product. Thus, under conditions of sustained [Ca2+]i and depolarization, such BK-type channels initially activate and then become silent. The inactivation of BK channels may play a role in the regulation of electrical excitability in these cells by altering the availability of BK channels for rapid repolarization after an action potential.

The most studied form of inactivation of BK channels has been in rat adrenal chromaffin cells (Solaro and Lingle, 1992; Solaro et al., 1995, 1997; Ding et al., 1998). The inactivation of chromaffin cell BK channels (BKi channels) shares some features with N-terminal type inactivation of voltage-dependent K+ channels (Hoshi et al., 1990). As with the ShakerB channel (Hoshi et al., 1990; Gomez-Lagunas and Armstrong, 1995), BKi inactivation arises from multiple trypsin-sensitive cytosolic domains (Ding et al., 1998). However, in contrast to the open channel-like blockade produced by the ShakerB N-terminal peptide (Choi et al., 1991; Demo and Yellen, 1991), cytosolic blockers of the BK channel pore do not compete with the native inactivation domain (Solaro et al., 1997). Previous work has failed to reveal a Slo alpha -subunit splice variant that might account for the inactivating phenotype (Saito et al., 1997).

Here we describe an EST sequence that encodes a homolog of the previously identified BK beta -subunits [beta 1, Knaus et al. (1994a); beta 2, Oberst et al. (1997)]. This new subunit (beta 3) confers inactivation on BK channels, and message-encoding beta 3 is found in both chromaffin cells and rat insulinoma tumor (RINm5F) cells. We also show that, in terms of inactivation rates, dependency on voltage and Ca2+, lack of effect of cytosolic blockers, sensitivity to trypsin, and relative insensitivity to charybdotoxin (CTX), the channels arising from the coexpression of Slo and beta 3 subunits share key properties with native BKi channels in chromaffin cells and RIN cells.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Isolation of cDNA clones. A novel member of the BK beta -subunit family, beta 3, was identified in the human EST database on the basis of homology with the known human beta 1 (Knaus et al., 1994b) and quail beta 2 (Oberst et al., 1997) subunits. The EST clone (accession number AA904191) containing the human beta 3 cDNA (accession number pending) then was obtained from a human lung neuroendocrine tumor library (Genome Systems, St. Louis, MO). The rat beta 3 homolog (accession number pending) was isolated from a RINm5F cDNA library (gift of Dr. Graeme Bell, University of Chicago, IL). The hybridization was performed in 1 M NaCl, 1% SDS, and 50% formamide at 37°C overnight and then washed with 2× SSC and 0.5% SDS. The screening membranes were exposed to x-ray film for 2 d. Initially, eight positive clones were identified in the RINm5F library. Of these, two purified positive cDNA clones contained full-length coding sequences of 1360 and 1042 bp, respectively. The DNA sequencing was performed with a BigDye Terminator Sequencing Kit (Applied Biosystems, Foster City, CA) on both strands. The beta -clones were all subcloned into pBF vector for in vitro RNA synthesis (Xia et al., 1998b).

Tissue distribution of BK beta 3 subunits. Northern blots were performed on membranes obtained from Clontech (Palo Alto, CA). Northern blots contained ~2 µg of poly(A+) RNA per lane from the indicated tissues. The loading of each lane was adjusted to contain an equal amount of human beta -actin per lane, based on a previous blot that used human beta -actin cDNA as a probe. The experimental procedure was as previously described (Xia et al., 1998a). Expression of rbeta 3 in adrenal and pancreatic tissue was determined by PCR and confirmed by sequence analysis. Total RNA from adrenal and pancreas was extracted and reversed-transcribed to cDNA (Promega, Madison, WI). Two primers (5' rbeta 3 5'-ACCATGACCTCCTGGACAAAAGG-3' and 3' rbeta 3 5'-TTCTGTGTGGTAGAGGAGGAGCT-3') were used for the PCR reaction (Taq polymerase, 32 cycles: 94°C for 30 sec, 52°C for 30 sec, and 72°C for 30 sec). Then the PCR products were subjected to automatic sequencing.

Expression constructs. The mSlo alpha -subunit (accession number L16912; Butler et al., 1993) used in these experiments was identical to that used in previous work from this lab (mbr5; Wei et al., 1994; Saito et al., 1997). Specifically, we used a construct containing no insert at the mammalian splice site 2 (Tseng-Crank et al., 1994). RNA from rat adrenal chromaffin cells also contains other splice site 2 variants (Saito et al., 1997), including a 59 or 61 amino acid insert (Saito et al., 1997; Xie and McCobb, 1998; Li et al., 1999). The longer forms confer an ~20 mV leftward shift in the voltage dependence of gating at a given Ca2+. In preliminary experiments in which the beta 3 subunit was coexpressed with the Slo construct containing the 59 amino acid insert, the resulting channels exhibited inactivation. The mSlo construct was subcloned in pBScMXT.

To make the hbeta 1 construct for expression, we used two hbeta 1 specific oligonucleotides each with a XbaI or SalI tail (5'-ACTATCTAGACCCAGTGAATATGGTGAAGAAGCT-3' and 5'-TACTAGTCGACTGGCTCTACTTCTGGGCCGC-3') in a PCR reaction (pfu polymerase, Stratagene), using hbeta 1 (accession number U38907; the generous gift of the Merck Research Labs, West Point, PA) as the DNA template. Then the product was digested and subcloned in pBF vector (Xia et al., 1998b).

The N-terminal deletion [hbeta 3(Delta 1-33)] construct also was produced via PCR reaction (5'-GGAATTCTCTAAGATGAGGAAAACAGTCACAGCAC-3' and 5'-TACTAGTCGACAAAAATTATTTTATCCATTTTTG-3') and subcloned in pBF. To generate C43A189 [hbeta 3(1-43):hbeta 1], we applied two rounds of PCR. In the first-round PCR, reaction A used hbeta 1 as the DNA template with two primers: one was a specific primer of 3' hbeta 1 (5'-TACTAGTCGACTGGCTCTACTTCTGGGCCGC-3'), and the second one was a bipartisan primer of sense strand of hbeta 3 and hbeta 1 (5'-ACAGCACTGAAGGCAGGAGAGACACGAGCCCTTTG-3'). Reaction B used hbeta 3 as a template with two primers: one was a specific primer of 5' hbeta 3 (5'-AAGGAATCTAGACCCTGGACCAACATTCTCTAAG-3'), and the other one was another bipartisan primer of antisense of hbeta 1 and hbeta 3 (5'-CAAAGGGCTCGTGTCTCTCCTGCCTTCAGTGCTGT-3'). This latter primer is the complement of the previous bipartisan primer (pfu polymerase, 32 cycles, 96°C for 30 sec, 51°C for 45 sec, and 72°C for 1 min). In the second-round PCR, the products of first-round PCR were used as a template (equal volume mixture of reaction A and B), and the two specific primers of hbeta 1 and hbeta 3 (5' hbeta 3 primer and 3' hbeta 3 primer) were used as primers (pfu polymerase, 32 cycles, 96°C for 30 sec, 51°C for 45 sec, and 72°C for 1.5 min) (Tucker et al., 1996). Then the final product was digested with XbaI and SalI and subcloned in pBF. All of the constructs were verified by DNA sequencing.

Expression in Xenopus oocytes. In vitro transcription was performed to prepare M7GppGp-capped cRNA for oocyte injection. First the plasmids were linearized with an appropriate enzyme (SalI for mSlo and MluI for beta -constructs). T3 (mSlo construct; Wei et al., 1994) or Sp6 (all beta -related constructs) RNA polymerases were used for run-off transcription (Xia et al., 1998b). Total cRNA (0.1-0.5 ng) was injected into stage IV Xenopus oocytes that were harvested the day before. By weight, the ratio of alpha - to beta -subunit RNA was 1:1 or 1:2, ensuring a large molar excess of beta -subunit RNA.

Electrophysiological recordings were performed after 1-7 d incubation of oocytes in ND-96 [containing (in mM) 96 NaCl, 2.0 KCl, 1.8 CaCl2, 1.0 MgCl2, and 5.0 HEPES, pH 7.5] supplemented with sodium pyruvate (2.5 mM), penicillin (100 U/ml), streptomycin (100 µg/ml), and gentamicin (50 µg/ml).

Electrophysiology. Currents were recorded in either inside-out or outside-out patches (Hamill et al., 1981). The generation of ensemble averages of detected channel openings (1-10 channels in patch) was done with patches from oocytes maintained for 1-3 d before recording. Patches used for G-V relations contained larger numbers of channels and were typically from oocytes maintained for 3-7 d. Currents typically were digitized at 10-50 kHz. Macroscopic records were filtered at 5 kHz (Bessel low-pass filter; -3 dB) during digitization. Single-channel records were filtered at 10 kHz (Bessel low-pass filter; -3 dB).

During seal formation the oocytes were bathed either in ND-96 or a frog Ringer's solution [containing (in mM) 115 NaCl, 2.5 KCl, 1.8 CaCl2, and 10 HEPES, pH 7.4]. For inside-out patches the patches were excised and moved quickly into a flowing 0 Ca2+ solution. The pipette extracellular solution was (in mM) 140 potassium methanesulfonate, 20 KOH, 10 HEPES, and 2 MgCl2, pH 7.0. Test solutions bathing the cytoplasmic face of the patch membrane contained (in mM) 140 potassium methanesulfonate, 20 KOH, 10 HEPES, pH 7.0, and one of the following: 5 mM EGTA (for nominally 0 Ca2+ and 1 µM Ca2+ solutions), 5 mM HEDTA (for 4 and 10 µM Ca2+ solutions, or no added Ca2+ buffer (for 60, 100, and 300 µM and 10 mM Ca2+ solutions). The methanesulfonate solutions were calibrated to be identical to a set of chloride-containing solutions, with free Ca2+ determined from a computer program (EGTAETC; E. McCleskey, Vollum Institute, Portland, OR). To accomplish this, we obtained the desired free Ca2+ by titrating the solution with calcium methanesulfonate until the electrode measurement of the methanesulfonate-based solution matched that of a chloride-based solution. The local perfusion of membrane patches was as described previously (Solaro and Lingle, 1992; Solaro et al., 1997).

Voltage commands and the acquisition of currents were accomplished with pClamp 7.0 for Windows (Axon Instruments, Foster City, CA). Currents were converted to conductances by using the measurement capabilities of the ClampFit program. For noninactivating currents the conductances were determined both from tail currents and from the peak current at the activation potential. Both estimates typically agreed within 5 mV. Ensemble averages were generated with custom software. Either null traces or traces obtained in 0 Ca2+ were used to generate an idealized leakage trace in the absence of channel openings. Then the idealized record was subtracted from records with channel openings before the detection and idealization of channel activity, using a 50% threshold detection procedure.

G-V curves for noninactivating variants were generated from both peak currents and tail currents with no significant difference in resulting fit values. G-V curves for inactivating variants were constructed from peak currents alone. Current values were measured by ClampFit (Axon Instruments), converted to conductances, and then fit with a nonlinear least-squares fitting program. Normalized G-V curves were fit with a Boltzmann equation with the form G(V) = {1 + exp[- (V - V0.5)]/k}-1. G-V curves in Figure 8 display the mean and SEM of the values at a given voltage for a set of patches. Because of variability in the G-V curves from individual patches, this flattens the G-V curve for the populations. Therefore, values for the means of each set of individual G-V curves for each patch are provided also.

The onset and recovery from blockade by CTX were fit as described previously (Saito et al., 1997) assuming a simple, first-order bimolecular blocking reaction involving two parameters: f, the forward rate of block (in units of M/sec) and b, the unblocking rate in seconds. The KD was calculated from b/f.

Experiments were done at room temperature (21-24°C). All salts and chemicals were obtained from Sigma-Aldrich (St. Louis, MO). Trypsin was applied at a concentration of ~0.25 mg/ml.

Removal of inactivation by trypsin. Predictions for the relationship between the apparent inactivation time constant (tau i) and the fraction of total BK current that is noninactivating current (fss) were determined on the basis of the following assumptions (Ding et al., 1998). (1) Channels can have 0-4 inactivation domains. All channels in the population start with some average number, n, of inactivation domains per channel. (2) For the total BK channel population the number of inactivation domains per channel follows a binomial distribution. (3) A single inactivation domain is sufficient to produce inactivation, and each inactivation domain acts independently to produce channel inactivation, with the microscopic rate of inactivation of one inactivation domain being kf (see MacKinnon et al., 1993; Ding et al., 1998). The value of fss allows for the use of the binomial distribution to calculate the fraction of channels of other stoichiometries. Then, for a given fss, a predicted macroscopic tau i can be predicted for the population of channels. Specifically, to determine the predicted tau i for a set of channels, we determined the contribution of channels of each stoichiometry from Im(t) = Am · exp(-m · kf · t), where m = 0-4 (the number of inactivation domains per channel) and Am is the fraction of channels containing m inactivation domains. For the set of channels:
I(t)=<LIM><OP>∑</OP><LL>m<UP>=</UP>0.4</LL></LIM> I<SUB><UP>m</UP></SUB>(t).

The resulting I(t) then was fit with a single exponential function to obtain the predicted tau i for a given fss. Although the inactivation time course for a population of channels with different numbers of inactivation domains should exhibit multiple exponential components, in practice the predicted components are difficult to distinguish even with simulated currents. The solid lines in Figure 4 were determined from this procedure with the additional assumption that, for the cases of n = 3.2 and 3.6, the initial fss before the initiation of the digestion was indistinguishable from 0.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Identification of a new BK beta -subunit that confers inactivation on BK channels

In a search for novel genes that might contribute to the BK beta -subunit family, a gene database search was performed and a human EST was identified that shares partial homology with previously described BK beta -subunits from smooth muscle (beta 1, Knaus et al., 1994a,b) and quail (beta 2, Oberst et al., 1997) (Fig. 1). A cDNA clone containing the full-length coding region of human beta 3 (hbeta 3) was obtained from a human lung neuroendocrine tumor source (Genome Systems, St. Louis, MO). Subsequently, a rat homolog (rbeta 3) of hbeta 3 was isolated from a RINm5F cDNA library. The deduced amino acid sequences of both human and rat beta 3 contain 235 residues that are identical except for 10 amino acids. There are 43% identities and 63% similarities between hbeta 1 and human hbeta 3. At the N terminal beta 3 has no apparent signal peptide, and a hydrophilicity plot shows that it has two hydrophobic regions toward the N and C terminals, which appear to correspond to the proposed transmembrane segments for the beta 1 subunit (Knaus et al., 1994a) (Fig. 1B). There are three potential N-glycosylation sites located between the two hydrophobic regions of beta 3. The predicted topology of beta 3 is similar to beta 1, having two transmembrane segments with both N and C terminals inside the cell and a large extracellular loop that has several N-glycosylation sites. beta 3 shares with beta 1 and beta 2 the presence of four conserved cysteines thought to contribute to the formation of disulfide bridges in the extracellular loop of the subunit.



View larger version (88K):
[in this window]
[in a new window]
 
Figure 1.   A family of beta -subunits for the Slo Ca2+-dependent voltage-gated K+ channel. Top, Amino acid alignment of human beta 1 (hbeta 1), quail beta 2 (cbeta 2), human beta 3 (hbeta 3), and rat beta 3(rbeta 3) subunits. Darkly shaded residues are those with identity to aligned residues in at least one other beta -subunit family member. Lightly shaded residues are those in which rat and human beta 3 subunits show identity. The two predicted transmembrane segments, TM1 and TM2 (Knaus et al., 1994a), are marked with lines both above and below. Residues proposed to be involved in the CTX binding of hbeta 1 (amino acids 90-94; Hanner et al., 1997) are marked with a row of asterisks. Bottom, Hydrophilicity plot (Kyte-Doolittle algorithm) of hbeta 3 with a window of nine amino acids.

The expression pattern of beta 3 in rat and human tissues

Northern blot analysis shows that hbeta 3 is highly expressed in human kidney, heart, and brain. In kidney and heart two major mRNA products, 1.6 and 2.9 kb, were observed, whereas in brain only a 2.9 kb product was detected (Fig. 2B). Low-level expression of hbeta 3 mRNA products also was detected in human lung, small intestine, spleen, and colon. The relative expression level of beta 3 in rat tissues differed somewhat from human tissues. As in human tissue, beta 3 was abundant in brain and heart. However, beta 3 was expressed more strongly in rat lung and less so in rat kidney, in comparison to human tissue.



View larger version (68K):
[in this window]
[in a new window]
 
Figure 2.   Northern blot analysis of beta 3 subunit distribution. Membranes were probed with radiolabeled beta 3 sequence (hbeta 3 for human tissues and rbeta 3 for rat tissues). A, Rat tissues: 1, testis; 2, kidney; 3, skeletal muscle; 4, liver; 5, lung; 6, spleen; 7, brain; 8, heart. B, Human tissues: 1, peripheral blood leukocytes; 2, lung; 3, placenta; 4, small intestine; 5, liver; 6, kidney; 7, spleen; 8, thymus; 9, colon; 10, skeletal muscle; 11, heart; 12, brain. C, Human brain: 1, thalamus; 2, substantia nigra; 3, whole brain; 4, hippocampus; 5, corpus callosum; 6, caudate nucleus; 7, amygdala; 8, putamen; 9, temporal lobe; 10, frontal lobe; 11, occipital pole; 12, spinal cord; 13, medulla; 14, cerebral cortex; 15, cerebellum.

We also explicitly tested for the presence of beta 3 message in tissues known to express inactivating BK channels (Solaro and Lingle, 1992; Li et al., 1999). PCR reactions using substrate cDNA that was reverse-transcribed for rat adrenal and pancreatic tissue generated a single band of the expected size. DNA sequence analysis confirmed that the product in rat adrenals and pancreas is identical to rbeta 3 (data not shown).

Coexpression of human or rat beta 3 with mSlo alpha -subunits confers inactivation on BK channels

Expression of either the human or rat beta 3 subunits with Slo alpha -subunits in Xenopus oocytes results in BK-type channels that exhibit rapid inactivation after depolarizing voltage steps in the presence of constant submembrane Ca2+ (Fig. 3A). Channels exhibited the characteristic large single-channel conductance (~250-260 pS in symmetrical K+). Ensembles of channel openings arising from the coexpression of the Slo and beta 3 constructs exhibited an apparent inactivation time constant (tau i) of ~25 msec at +100 mV and 10 µM Ca2+. Figure 3B plots ensemble current averages for the patch shown in A for 0, 1, 4, and 10 µM Ca2+. As Ca2+ is increased, the apparent tau i becomes faster. Patches with a larger number of channels exhibited similar inactivation behavior (Fig. 3C for Slo with hbeta 3). Figure 3D displays normalized currents activated at different command potentials but with 10 µM Ca2+. Stronger membrane depolarization increases the apparent tau i. Figure 3E plots the measured tau i as a function of Ca2+ and voltage for currents generated by channels in patches from oocytes injected with Slo and human beta 3. The onset of inactivation appears to reach both a Ca2+ and voltage-independent limiting rate, as has been observed for native BKi channels in chromaffin cells and RIN cells. Estimates of tau i from ensembles of detected channel openings were indistinguishable from those shown in Figure 3E (data not shown). These properties of tau i closely mirror the behavior of BKi channels in RIN and chromaffin cells.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 3.   Coexpression of the beta 3 subunit with the Slo alpha -subunit produces inactivating BK channels. A, Traces show channel openings from an inside-out patch from a Xenopus oocyte injected with cRNA encoding both rat beta 3 and mouse Slo alpha -subunits. Channels were activated by voltage steps to +100 mV, after a prepulse to -140 mV to remove inactivation, in the presence of 0, 1, or 10 µM Ca2+. Averages of openings for each condition are shown below the traces. B, Left, Ensemble-averaged currents are overlaid to emphasize differences in the amplitude and time course of current activation and inactivation for 0, 1, 4, and 10 µM Ca2+. B, Right, Currents obtained at 1, 4, and 10 µM were normalized to the peak current values to allow for a comparison of the time course of inactivation. Increases in Ca2+ result in a faster apparent tau i. C, Traces show macroscopic currents recorded from excised inside-out patches, with a larger number of channels resulting from the hbeta 3 construct coexpressed with mSlo. Activation was elicited at potentials from -100 through +100 mV with 0, 1, and 10 µM Ca2+. D, Slohbeta 3 currents activated with 10 µM Ca2+ at the indicated voltages were normalized to the same amplitude to show that the apparent tau i becomes faster with increased depolarization. E, The tau i is plotted as a function of command potential for 1, 4, and 10 µM Ca2+. With sufficient depolarization a similar limiting tau i of ~25-30 msec is achieved for each [Ca2+].

Inactivation properties of Slobeta 3 channels share key similarities with native BKi channels found in RIN and chromaffin cells

We also wished to determine whether other properties of currents arising from Slobeta 3 subunits are consistent with the known properties of BKi channels in RIN and chromaffin cells.

Inactivation of BKi channels in native cells involves multiple trypsin-sensitive inactivation domains (Ding et al., 1998). To examine this possibility, we applied trypsin (0.5 mg/ml) for 3-5 sec periods to inside-out patches, and current averages were generated from channels activated between trypsin applications. In Figure 4A, trypsin was applied to a patch containing a single inactivating channel. Inactivation was removed gradually by trypsin and eventually was abolished completely. Ensemble averages from patches with one or a small number of channels indicated that trypsin slowed tau i, although stochastic fluctuations resulted in large variation in such estimates. When patches with larger numbers of channels were used (n = 4 patches), trypsin clearly resulted in the gradual removal of inactivation, in a manner consistent with the inactivation of Slobeta 3 channels arising from multiple independent cytosolic inactivation domains per channel (Fig. 4B). For a given number of inactivation domains per channel, tau i is predicted to change in accordance with the fraction of current that is noninactivating (see Materials and Methods) (MacKinnon et al., 1993). Such a relationship is plotted for one patch in Figure 4C, suggesting that the inactivation of Slobeta 3 currents is consistent with four independent inactivation domains. As in previous work with native BKi channels (Ding et al., 1998) and earlier work with ShakerB K+ channels (Gomez-Lagunas and Armstrong, 1995), with >50% removal of inactivation the estimates of prolongation are vulnerable to additional slow components of inactivation, resulting in deviation from the predicted relationships. The results in Figure 4 support the idea that multiple independently acting inactivation domains participate in the Slobeta 3 inactivation process. The results also suggest a stoichiometry of four inactivation domains per channel. However, because the experimentally determined relationship between the fractional prolongation of tau i and the fraction of noninactivating current (fss) is quite sensitive to rather small variability in the measured estimates of the apparent tau i before the removal of inactivation, we feel that any conclusion concerning the stoichiometry of inactivation is only tentative at present.



View larger version (36K):
[in this window]
[in a new window]
 
Figure 4.   Selective digestion of the inactivation mechanism by trypsin applied to the cytosolic membrane face. A, Trypsin (0.5 mg/ml) was applied briefly to a patch containing one BKi channel resulting from the expression of hbeta 3 with mSlo alpha -subunits. The cytosolic face of the patch was bathed with 10 µM Ca2+. The left column shows traces before trypsin exposure, the middle column shows traces after partial trypsin digestion, and the right column shows traces after removal of inactivation. Averages expressed as channel open probability (PO) from each set of sweeps are shown below the individual traces. B, Ensemble currents from a patch with a larger number of channels are displayed. Channels were activated with 10 µM Ca2+, with voltage steps to +100 mV. Trypsin was applied for 3-5 sec between the generation of each ensemble. As inactivation is removed, there is also a slowing in the apparent tau i. C, The fractional prolongation of tau i is plotted as a function of the fraction of peak current that does not inactivate by the end of each voltage step. When a limiting tau i of 28 msec is used, the experimental points closely follow the predictions for a population of channels, each of which initially contained four inactivation domains per channel.

Inactivation of native BKi channels also exhibits one feature that distinguishes it from inactivation of the Shaker family of voltage-dependent K+ channels (Choi et al., 1991) and from inactivation of BK channels observed in hippocampal neurons (Hicks and Marrion, 1998). Specifically, cytosolic blockers of BK channels do not slow the native BKi inactivation process (Solaro et al., 1997), indicative that occupancy of a site within the mouth of the ion permeation pathway does not hinder movement of the inactivation domains to their blocking sites. This contrasts with inactivation of BK channels in hippocampal neurons in which TEA and the ShakerB ball peptide have been shown to compete with the inactivation process (Hicks and Marrion, 1998). We therefore tested whether the rather bulky quaternary ammonium cytosolic blocker of BK channels, the lidocaine derivative QX-314, might hinder the Slobeta 3 inactivation process. QX-314 produces a voltage-dependent reduction in BK single-channel current (Oda et al., 1992; Solaro et al., 1997) consistent with a rapid open-channel block mechanism in which QX-314 occupies a site within the ion permeation pathway. In Figure 5A, the cytosolic application of 2 mM QX-314 reduced the averaged peak current to ~24% of the control amplitude, having only small effects on tau i. For a simple model in which QX-314 is proposed to compete with the native inactivation process, a reduction of current to 24% is predicted to produce a 4.17-fold prolongation of tau i (Choi et al., 1991; Ding et al., 1998). For four patches, 2 mM QX-314 produced a 1.18 ± 0.07-fold prolongation of tau i. Thus, the effect of QX-314 is inconsistent with a simple competitive scheme, indicative that inactivation conferred by the beta 3 subunit does not involve interaction with the site occupied by QX-314.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 5.   A cytosolic blocker does not slow the inactivation of Slohbeta 3 currents. A, Ensemble current averages obtained before, during, and after the application of 2 mM QX-314 to the cytosolic face of an inside-out patch expressing Slohbeta 3 channels are plotted. Peak current was reduced to ~24% by QX-314. A simple competitive interaction between QX-314 and movement of the inactivation domain to its blocking site predicts an ~4.17-fold prolongation in current decay, indicated by the dotted line. B, Normalized currents are plotted to show that QX-314 appears to produce a slight prolongation of current decay. However, the magnitude of the prolongation is inconsistent with that expected for a simple competitive interaction with the inactivation domain and site occupied by QX-314.

The beta 3 subunit confers a reduced sensitivity to CTX

BKi channels in chromaffin cells (Ding et al., 1998) and RIN cells (Li et al., 1999) exhibit a reduced sensitivity to the scorpion venom, CTX (Ding et al., 1998). Specifically, blockade of BKi current by CTX exhibits a slower onset and slower recovery than were observed for noninactivating BK current in chromaffin cells (Ding et al., 1998). If incorporation of the beta 3 subunit accounts for the inactivating BKi phenotype in these cells, it also must confer a reduced sensitivity to CTX. In Figure 6, the sensitivity of Slo, Slobeta 1, and Slobeta 3 channels is compared by using outside-out patches. When 5 mM TEA was applied in the same experiments, complete block and recovery from TEA blockade occurred within the first voltage step after the solution change, an interval of 10-20 sec. Thus, the time course of onset and recovery from block by CTX should reflect the kinetics of the CTX blocking reaction. With Slo expression alone, 20 nM CTX produces a relatively complete and rapid block of current. With coexpression of hbeta 1 (Fig. 6B2), blockade by 20 nM CTX was somewhat less effective at blocking in current, although 100 nM CTX produced an almost complete block. In contrast, an application of 100 nM CTX of duration comparable to that in Figure 6B2 produced only a slowly developing and incomplete block of the Slohbeta 3 current (Fig. 6B3). Qualitatively, these results indicate that the beta 3 subunit appears to decrease the amount of block by CTX at a given concentration and to slow the rate of onset of block.



View larger version (34K):
[in this window]
[in a new window]
 
Figure 6.   The beta 3 subunit confers a reduced sensitivity to CTX on the Slo subunit. Currents were elicited in outside-out patches with 10 µM pipette Ca2+. Each patch was perfused with the concentrations of CTX indicated by the horizontal bars. For each patch 1 or 5 mM TEA also was applied separately to show that the onset and recovery from TEA block were rapid relative to the time course of CTX block. In A1-D1, raw currents obtained for control, CTX, and recovery salines are shown for mSlo alone (A), mSlo plus hbeta 1 (B), mSlo plus hbeta 3 (C), and mSlo plus beta 3(Delta 1-33) (D). In A2-D2, normalized peak current amplitudes from the patches shown above are plotted as a function of elapsed experimental time. The lines indicate the optimal fit to a first-order blocking reaction (see Materials and Methods) in which the forward rate of block (f, M/sec) and the unblocking rate (b, per sec) are the only free parameters. The KD values calculated from the fit rates are given on the graph, with mean values given in Results.

Blockade by CTX for BK channels has been described by a relatively simple bimolecular reaction (MacKinnon and Miller, 1988). With the assumption of this type of reaction, an estimate of the approximate KD for block by CTX can be obtained from a simultaneous fit of the onset and recovery from block (see Materials and Methods), assuming that the time course of CTX concentration changes is sufficiently rapid relative to the time course of the blocking reactions. This procedure takes advantage not only of information available from the magnitude of blockade produced by one or two concentrations of CTX but also of the rates of the blocking reaction. With the use of this procedure, CTX blocks Slo currents with an IC50 of 3.5 ± 0.6 nM (mean ± STD; n = 4 patches) and blocks Slobeta 1 currents with an IC50 of 13.9 ± 2.4 nM (n = 3). Blockade of Slobeta 3 currents was more difficult to assess quantitatively, because washout from CTX blockade was difficult to achieve (Fig. 6C). This difficulty in achieving reversibility from CTX block of inactivating BK currents also was observed in chromaffin cells (Ding et al., 1998) and RIN cells (Li et al., 1999). Assuming a simple block model, in which recovery from block is expected to be complete, the example in Figure 6C yields an IC50 of ~29 nM, although the data are not fully described by this model. With the use of this procedure for three cells with at least partial recovery from block, the IC50 was 49.8 ± 26.9 nM. Because of the difficulty in achieving adequate recovery, this value certainly overestimates the sensitivity of the Slobeta 3 currents to CTX. The difficulty in obtaining adequate recovery from CTX block of the Slobeta 3 construct may indicate that a simple block scheme may not be fully adequate to describe the blocking mechanism. However, qualitatively, the slower onset of block and weaker blocking effect of CTX on the Slobeta 3 currents relative to Slo alone or Slobeta 1 are consistent with the weaker effects of CTX on BKi currents in RIN and chromaffin cells (Ding et al., 1998). This suggests that the beta 3 subunit may account for the reduced CTX sensitivity of BKi channels in these cells.

Two other studies also have reported the existence of BK channels with reduced sensitivity to CTX, but these other channels were noninactivating in nature. First, some BK-type channels studied in bilayers appear to lack sensitivity to CTX (Reinhart et al., 1989). Second, BK channels in peptide-secreting terminals of the posterior pituitary are CTX-resistant (Bielefeldt et al., 1992). Because these other CTX-resistant BK channels are noninactivating, it raises the possibility that additional, unidentified beta -subunits may contribute to the properties of these other channels.

The beta 3 N terminal is necessary and sufficient for inactivation

The additional N-terminal sequence of the beta 3 peptide suggested that this region was responsible for the inactivation behavior. To address this issue, we created a construct [beta 3(Delta 1-33)] lacking the first 33 amino acids of the beta 3 sequence. Expression of beta 3(Delta 1-33) with Slo completely abolished any rapid inactivation of current (Fig. 7A). To verify that the beta 3(Delta 1-33) subunit actually was expressed and associated with Slo subunits, we examined the IC50 for blockade of Slobeta 3(Delta 1-33) by CTX and found it to be 44.5 ± 16.9 nM (n = 3) (see Fig. 6D), comparable to results with the intact beta 3 subunit but distinct from Slo alone. Thus, removal of the N terminal from the beta 3 subunit abolishes inactivation but maintains a change in CTX sensitivity similar to that produced by the intact beta 3 subunit.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 7.   The N terminal of the beta 3 subunit is necessary and sufficient for inactivation. A, Left, Currents are shown resulting from the coexpression of mSlo with the hbeta 3(Delta 1-33) construct in which 33 amino acids were removed from the hbeta 3 N terminal. A, Right, Shown are currents resulting from the coexpression of mSlo with the hbeta 3(1-43):hbeta 1 construct in which the initial 43 amino acids of hbeta 3 replaced the first 12 amino acids at the N terminal of hbeta 1. In both cases the currents were activated by the indicated voltage steps with 10 µM Ca2+. No inactivation is observed with hbeta 3(Delta 1-33), whereas inactivation is observed with hbeta 3(1-43):hbeta 1.

To assess further the role of the beta 3 N terminal, we used amino acids 1-43 of the beta 3 subunit to replace the N-terminal 1-12 amino acids of the beta 1 subunit [hbeta 3(1-43/hbeta 1)]. As shown in Figure 7B, this addition of the beta 3 N terminal to the beta 1 subunit was sufficient to confer inactivation behavior on the beta 1 subunit. The apparent tau i for this construct was indistinguishable from that of beta 3 (data not shown).

The beta 3 subunit shifts gating of Slo subunits

A major functional role of the previously described beta 1 and beta 2 subunits is to produce a shift in activation by Ca2+ to more negative membrane potentials (McManus et al., 1995; Dworetzky et al., 1996; Wallner et al., 1996; Saito et al., 1997; Ramanathan et al., 1999). Thus, smooth muscle BK channels or other BK channels containing a beta 1 subunit can be activated by elevations of submembrane Ca2+ even at membrane potentials near rest. In contrast, other BK channels in native cells appear to exhibit sensitivities to Ca2+ more similar to the Slo alpha -subunit in the absence of any beta -subunit (McManus, 1991; Saito et al., 1997).

Given the important role of the beta 1 subunit in the regulation of gating of the alpha -subunit, we examined the activation of current by 10 µM Ca2+ at various voltages for six different constructs: Slo alone, Slohbeta 3, Slo(Delta 1-33)beta 3, Slo[beta 3(1-43)]beta 1, Slohbeta 1, and Slorbeta 3. For constructs that exhibited inactivation (Slohbeta 3 and Slo[beta 3(1-43)]beta 1), peak currents were used to generate conductance-voltage (G-V) curves. We expect that estimates of G-V curves for inactivating currents that use the peak current will reduce the steepness of the apparent voltage dependence, thereby producing a somewhat more positive estimate of the V0.5. However, the threshold for current activation should be similar with inactivation intact or removed. For the other constructs the G-V curves were generated from both peak and tail currents, with only small differences in the results. Figure 8 plots normalized G-V curves for four constructs. Clearly, both the beta 1 and beta 3 subunits result in a substantial shift in the voltage range over which the channel effectively gates with 10 µM Ca2+.



View larger version (35K):
[in this window]
[in a new window]
 
Figure 8.   The beta 3 subunit shifts gating of the mSlo alpha -subunit. Normalized conductance-voltage curves were constructed from each of the indicated constructs by using 10 µM Ca2+ to activate the currents. G-V curves from individual patches were normalized separately and then averaged. This results in a flattening of the G-V curve for the averages. The fit values for the V0.5 for the grouped data for each construct included the following: for Slo alone, 24.5 ± 0.5 mV (± 90% confidence limit of fit value); for Slo plus hbeta 3, -28.5 ± 1.4 mV; for Slo plus beta 3(Delta 1-33), -21.4 ± 0.6 mV; and for Slo plus hbeta 1, -28.1 ± 0.9 mV. For comparison, the means of the V0.5 values from each individual patch included the following: for Slo alone, 25.8 ± 11.8 mV (mean ± STD; n = 5); for Slo plus hbeta 3, -32.6 ± 11.5 mV (n = 11); for Slo plus beta 3(Delta 1-33), -22.2 ± 19.3 mV (n = 4); and for Slo plus hbeta 1, -27.2 ± 18.0 mV (n = 9). For six patches with the rat beta 3 coexpressed with Slo, the V0.5 was -19.5 ± 7.8 mV. For nine patches for the beta 3(1-43):beta 1 construct expressed with Slo, the V0.5 was -55.5 ± 10.2 mV.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The present results demonstrate that the coassembly of Slo alpha -subunits with the beta 3 subunit is responsible for expression of inactivating BK channels in RIN and chromaffin cells. Furthermore, the presence of the beta 3 subunit in a number of other tissues, including brain, suggests a more general role of inactivating BK channels than previously realized. The existence of native BK channels with phenotypes unaccounted for by the known beta -subunits and known Slo splice variants suggests that additional accessory subunits may remain to be identified. For example, the inactivation of hippocampal BK channels (Hicks and Marrion, 1998) cannot be accounted for by the Slo splice variants and beta -subunits so far described. Similarly, CTX-resistant, but noninactivating, BK channels found in brain (Reinhart et al., 1989; Bielefeldt et al., 1992) would appear to require components other than those so far described. If so, the tissue-specific expression of beta -subunits might help to explain the large phenotypic diversity among native BK channels (McManus, 1991).

Our results indicate that the beta 3 subunit is present in a number of both neuronal and non-neuronal tissues. Although the inactivation of BK-type channels has been observed in a number of cell types [Drosophila muscle, Salkoff (1983); chromaffin cells, Solaro and Lingle (1992); RIN cells, Li et al. (1999); hippocampal neurons, Ikemoto et al. (1989) and Hicks and Marrion (1998); skeletal muscle, Pallotta (1985); frog hair cells, Armstrong and Roberts (1999)], it is unclear to what extent the beta 3 subunit plays a role in many of these cases.

In chromaffin cells and RIN cells the apparent tau i of inactivation reaches a relatively voltage-independent and Ca2+-independent value at more positive voltages and more elevated Ca2+. In chromaffin cells this value is in the range of 25-40 msec (Solaro and Lingle, 1992; Prakriya et al., 1996). The variability in the chromaffin cells probably arises from the possibility that the BK channels may, on average, contain less than a full complement of four inactivation domains per channel (Ding et al., 1998). In fact, an implication of this latter study was that tau i for channels containing four inactivation domains should approach ~25-28 msec. This is identical with the limiting tau i observed here. In contrast, in hippocampus (Hicks and Marrion, 1998) and skeletal muscle (Pallotta, 1985) the inactivation of BK channels is markedly slower (tau i approximately hundreds of milliseconds). In frog hair cells (Armstrong and Roberts, 1999) the inactivation of a Ca2+-dependent K+ current is faster (tau i ~3 msec). Thus, the properties of the apparent tau i observed for the Slobeta 3 currents are identical to those of BKi channels in chromaffin cells but differ from those observed in the other tissues.

The inability of QX-314 to hinder the Slobeta 3 inactivation process is similar to the lack of effect of QX-314 on chromaffin cell (Solaro et al., 1997) and RIN cell (Li et al., 1999) BKi inactivation. In comparison, tetraethylammonium and the Shaker ball peptide cause inactivated BK channels in hippocampal neurons to recover from inactivation (Hicks and Marrion, 1998), suggesting a competition between the inactivation domain and the blockers. This again suggests that the inactivation mechanism in the hippocampal cells differs from that resulting from the action of the beta 3 subunit. Thus, although the beta 3 subunit may account for BK inactivation in RIN and chromaffin cells, the molecular basis for inactivation in other tissues remains unknown.

One property of the Slobeta 3 currents does vary somewhat from BKi currents in chromaffin cells. Specifically, the voltage of half-activation at 10 µM Ca2+ for Slobeta 3 channels is approximately -20 to -30 mV. This is negative to that reported for the activation of BKi currents in native chromaffin cells by 10 µM Ca2+, which was ~3 mV (Prakriya et al., 1996). Although a difference in methodology might account for these differences, two other factors may contribute to this difference. First, the stoichiometry of the assembly of beta - and alpha -subunits may influence the gating range of native BK channels. Second, there is evidence that the ability of beta -subunits to influence the gating range depends on the identity of the alpha -subunit splice variant (Ramanathan et al., 1999). Either or both of these factors may contribute to differences in the gating range between native BK channels in chromaffin cells and channels arising from the coexpression of beta 3 and alpha -subunits. The possibility that <4 beta -subunits may be associated with each BK channel in chromaffin cells is consistent with the observation that, on average, BKi channels contain only two to three inactivation domains per channel (Ding et al., 1998). Furthermore, chromaffin cells express multiple alpha -subunit splice variants (Saito et al., 1997), one of which may affect the ability of an associated beta -subunit to shift gating (Ramanathan et al., 1999). A complete answer to this issue will require a determination of the exact molecular composition(s) of BK channels in chromaffin cells.

The role of beta -subunits in defining CTX sensitivity

Despite the general acceptance of CTX as a blocker of BK channels, there is little detailed information about the effective IC50 values for block in native tissues. This certainly stems in part from the challenges associated with the slow dissociation of CTX. Some studies also have described CTX-resistant BK channels (Reinhart et al., 1989; Bielefeldt et al., 1992). Our previous studies on chromaffin and RIN cells (Ding et al., 1998; Li et al., 1999) demonstrated a reduced CTX sensitivity (IC50 ~50-100 nM) for BKi channels relative to noninactivating BK channels (IC50 ~2-4 nM). Although our results with CTX only provide a qualitative comparison of the effect of beta -subunits in defining the CTX sensitivity of different Slo channels, the similar resistance of the BKi and Slobeta 3 channels to CTX is consistent with the proposed role of beta 3 subunits in the formation of BKi channels. Our results also suggest that there are differences between the beta 1 and beta 3 subunits in determining CTX sensitivity. Residues on the beta 1 subunit responsible for influencing the affinity of CTX for the Slobeta complex have been determined (Hanner et al., 1998). Surprisingly, the residues proposed to account for CTX interaction with the beta 1 subunit are identical in the beta 3 subunit. Thus, other differences between the beta 1 and beta 3 subunits must account for the differences in CTX sensitivity.

The mechanism of BKi inactivation

The present results indicate unambiguously that the N-terminal domain of the beta 3 subunit is responsible for the inactivation of the Slobeta 3 channels. Although inactivation of BKi channels shares some features in common with N-terminal-mediated inactivation (Solaro et al., 1997), there are also clear differences. Unlike inactivation mediated by the N terminal of the ShakerB alpha -subunit (Choi et al., 1991; Demo and Yellen, 1991), inactivation mediated by the tethered beta 3 N-terminal domain involves a binding site not influenced by occupancy of the ion permeation pathway by QX-314. Thus, the beta 3 N-terminal domain appears to block the BK channel at a position probably not homologous with the Shaker pore site acted on by the ShakerB N-terminal structures.

During the revision of this manuscript, a paper describing the identical human beta -subunit appeared (termed beta 2 in Wallner et al., 1999). Our results share a number of observations with this other study but differ on some interesting points. First, in the other work, Northern blots did not reveal the beta 3 subunit in adrenal tissue. In contrast, our results support the view that the beta 3 subunit can account specifically for BK channel inactivation in RIN cells and chromaffin cells. Specifically, we showed by PCR that the beta 3 subunit is found in pancreatic and chromaffin cell RNA and that the beta 3 subunit is present in a RIN cell library. It is possible that low message levels may result in the difficulty of detecting the beta 3 subunits by Northern blots. Second, our results indicate that QX-314 does not compete with the native inactivation process mediated by the beta 3 subunit, similar to the properties of BKi channels in native cells (Solaro et al., 1997). However, Wallner et al. (1999) report that TEA does compete with a free beta 3 N-terminal ball peptide for blockade of the Slo channel. To address this potential discrepancy, we therefore have examined the ability of QX-314 to compete with a 26-amino-acid beta 3 N-terminal